Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT02890953
PHASE2

Efficacy and Safety of Pneumostem® for IVH in Premature Infants (Phase 2a)

Sponsor: Samsung Medical Center

View on ClinicalTrials.gov

Summary

The objective of this study is to evaluate the efficacy and safety of a single intraventricular administration of Pneumostem® for treatment of Intraventricular hemorrhage (IVH) in high-risk premature infants by comparing Pneumostem-treated group with a control group.

Official title: Efficacy and Safety Evaluation of Pneumostem® Versus a Control Group for Treatment of IVH in Premature Infants (Phase 2a)

Key Details

Gender

All

Age Range

Any - 28 Days

Study Type

INTERVENTIONAL

Enrollment

22

Start Date

2017-03-28

Completion Date

2025-12

Last Updated

2025-04-13

Healthy Volunteers

No

Interventions

DRUG

Pneumostem

direct intracerebroventricular injection of mesenchymal stem cells via ventricular tap

DRUG

Normal saline

direct intracerebroventricular injection of normal saline via ventricular tap

Locations (1)

Samsung Medical Center

Seoul, South Korea